Page last updated: 2024-08-17

adenosine monophosphate and chronic COVID syndrome

adenosine monophosphate has been researched along with chronic COVID syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Boglione, L; Borrè, S; Cantone, M; Di Pasquale, F; Domenicale, B; Esposito, M; Meli, G; Moglia, R; Poletti, F; Rostagno, R; Scianguetta, C	1

Other Studies

1 other study(ies) available for adenosine monophosphate and chronic COVID syndrome

Article	Year
Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM : monthly journal of the Association of Physicians, 2022, Jan-09, Volume: 114, Issue:12 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Incidence; Intensive Care Units; Post-Acute COVID-19 Syndrome; Prospective Studies; Risk Factors; SARS-CoV-2	2022

Article

Year

Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?

QJM : monthly journal of the Association of Physicians, 2022, Jan-09, Volume: 114, Issue:12

Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Incidence; Intensive Care Units; Post-Acute COVID-19 Syndrome; Prospective Studies; Risk Factors; SARS-CoV-2

2022